Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
R&D Systems™ Recombinant Human CCL1/I-309 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Supplier: R&D Systems™ 272I050
This item is not returnable.
View return policy
Description
The Recombinant Human CCL1/I-309 Protein is derived from E. coli. The Recombinant Human CCL1/I-309 Protein has been validated for the following applications: Bioactivity.Specifications
Lyophilized from a 0.2μm filtered solution in Acetonitrile and TFA with BSA as a carrier protein. | |
8.5 kDa | |
50μg | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
Recombinant |
6346 | |
CCL1/I-309/TCA-3 | |
E. coli-derived human CCL1/I-309/TCA-3 protein Lys24-Lys96 | |
Unconjugated | |
97%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
Provide Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?
Provide Content Correction